AllAnalyst Report
logoArgusMarch 13, 2024

Humana Inc.: Downgrading to HOLD from BUY

Symbols
HUM
Sector(s)
Healthcare
Rating
Current Price
$305.90
Price Target
Earnings Estimate
Summary

Humana is a health benefits company that offers coordinated health insurance coverage and related services through a variety of plans for retirees, employer groups, and government-sponsored programs, such as Medicare Advantage and Medicaid. Humana serves nearly 17 million medical members and 5 million specialty and dental members. The company's CenterWell health services segment offers PBM services, home care services, and primary care services. HUM shares are a component of the S&P 500. Humana has a strong position in the Medicare Advantage (MA) market and growth opportunities in its healthcare services business. The MA market is expanding rapidly as aging Americans seek s

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade

Analyst Profile

David H. Toung

Senior Analyst: Medical Devices & Healthcare Services
David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.